SLC39A11 and urinary bladder cancer: Moreover, out of 253 bladder cancer patients reported in TCGA, two had tumors that contained deleterious missense mutations in ZIP11. These data led to the identification of ZIP11 as a contributor to bladder cancer (Wu et al., 2015).